Stay updated on Safety and Efficacy of Anti-PD-1 Combination Therapies Clinical Trial
Sign up to get notified when there's something new on the Safety and Efficacy of Anti-PD-1 Combination Therapies Clinical Trial page.

Latest updates to the Safety and Efficacy of Anti-PD-1 Combination Therapies Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2 on the page history.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedAdded revision v3.5.0 to the history and removed revision v3.4.3 from the list.SummaryDifference0.0%

- Check46 days agoChange DetectedA new revision entry v3.4.3 was added to the history, and the previous v3.4.2 entry was removed.SummaryDifference0.0%

- Check75 days agoChange DetectedAdded a Revision: v3.4.2 to the history; removed the prior funding-status notices about lapses and operating updates.SummaryDifference0.3%

- Check82 days agoChange DetectedAdded a site-wide funding/operational status notice and updated the page revision to v3.4.1 (replacing v3.4.0). These changes do not alter the trial record content.SummaryDifference0.3%

- Check89 days agoChange DetectedThe BI 754091 platform trial description was deleted and replaced with an Ezabenlimab-based platform trial description, and a new 'Results Posted' entry was added, with color-coded changes for Adverse Events, Outcome Measures, IPDSharing, and Study Status. The update also enables 'Show glossary' and documents the 3.4.0 revision with UI cues about how additions and deletions are presented.SummaryDifference0.8%

Stay in the know with updates to Safety and Efficacy of Anti-PD-1 Combination Therapies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of Anti-PD-1 Combination Therapies Clinical Trial page.